Form D · Biotechnology
Andrew Technologies LLC
Tustin, CA · CIK 0001516391
Offering snapshot reported Jan 19, 2017 · SEC filing
- Reported sold
- $738K Offering amount: $3M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 19, 2017 | Initial | $738,350 | No comparison | 14 | SEC filing |
| Dec 17, 2015 | Initial | $7,783,389 | No comparison | 28 | SEC filing |
| May 31, 2013 | Initial | $6,261,769 | No comparison | 13 | SEC filing |
| Mar 24, 2011 | Initial | $6,999,684 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-278808
Secured Convertible Promissory Notes and the equity securities issuable upon conversion of such Notes
Source: Form D, filed Jan 19, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas A. Albright | Director, Executive |
| Mark Andrew | Director, Executive |
| Mark S. Andrew, M.D. | Director, Executive |
| Ronald Castillo | Executive |
| Robert Chefitz | Director |
| John Coelho | Director |
| Herbert Crane | Executive |
| Luis Davila | Executive |
| David De Leeuw | Director |
| William Doyle | Director |
| Stephane Gobron | Executive |
| Timothy Langloss | Director |
| Mylina Lincoln Andrew | Director |
| Brian Murray | Director |
| Lennart Perlhagen | Director |
| Gert Lennart Perlhagen | Director |
| Sidharta Prakash | Director |
| Siddharth Prakash, M.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1421 Edinger Avenue Suite D
Tustin, CA, 92780
Tustin, CA, 92780